Patients with heart failure often have a dismal prognosis as the condition usually worsens over time, but a new study aims to see if digital health technologies can improve their prospects.
Astellas Pharma is to buy bioelectronic medical devices firm iota Biosciences in a deal worth up to $429m, building on a previous research partnership.
US startup Blue Oak Pharma has joined a lengthening list of companies turning to Exscientia of the UK for its expertise in applying artificial intelligence to drug discovery.
A record number of health and medtech companies have been included in the Sunday Times Sage Tech Track 100, which ranks Britain’s private tech companies.
It was supposed to be at the heart of the UK government’s fight against coronavirus – but after months of delays it has emerged that the NHS COVID-19 app has sent just one alert over a pote
A pharma company’s core mission is to improve patient outcomes. This hinges on effectively influencing HCP clinical behaviour and driving disease education.